News Focus
News Focus
icon url

Skiluc

12/05/21 9:50 PM

#63002 RE: trader59 #62999

Auctus doesnt need to own it for the shares to be reserved and accounted for in the OS.

And their deal guarantees $10? Sweet. And this company is crazy undervalued. NASDAQ is nothing but comparisons. Not even performance. Look at Tesla. Or others. Performance? Ha. Its all about comparisons. And comparing BRTX to other biotech with FDA cleared clinical trials… its not only undervalued. But extremely undervalued.

And i thought i was new.
icon url

Money $hot

12/05/21 10:20 PM

#63011 RE: trader59 #62999

What you stated about it being pretty straight forward may be E Z for you to say but can you explain how the company satisfied the Bid or Closing Price of maybe $3 USD PRIOR TO UPLISTING? Meaning, at the time of application the bid/closing price was trading around .003 Cent. That's miles away from $3. So how is the timeline drawn in the case of BRTX where prior to it's application it never traded anywhere near $3. If you really know that answer please explain it like I'm in the 5th grade. I'm guessing BRTX fell under the "Net Income Standard" considering they didn't/don't have $50 Million anything.

Have a look here: https://investorshub.advfn.com/uimage/uploads/2021/12/4/porucNasdaq_Initial_Listing_Guide_page-0001.jpg

Thx

MS